Metropolitan Life Insurance Company (MetLife)’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-14,313
| Closed | -$1.03M | – | 2422 |
|
|
2021
Q4 | $1.03M | Sell |
14,313
-148
| -1% | -$10.7K | 0.01% | 936 |
|
|
2021
Q3 | $1.11M | Sell |
14,461
-385
| -3% | -$30.9K | 0.02% | 874 |
|
|
2021
Q2 | $1.15M | Buy |
14,846
+269
| +2% | +$19.1K | 0.02% | 900 |
|
|
2021
Q1 | $899K | Buy |
14,577
+922
| +7% | +$58.4K | 0.01% | 1023 |
|
|
2020
Q4 | $891K | Sell |
13,655
-189
| -1% | -$10.9K | 0.01% | 962 |
|
|
2020
Q3 | $686K | Sell |
13,844
-793
| -5% | -$40.9K | 0.01% | 983 |
|
|
2020
Q2 | $698K | Sell |
14,637
-26,468
| -64% | -$1.28M | 0.01% | 976 |
|
|
2020
Q1 | $1.75M | Sell |
41,105
-1,918
| -4% | -$94.8K | 0.04% | 437 |
|
|
2019
Q4 | $2.53M | Sell |
43,023
-1,238
| -3% | -$67.2K | 0.04% | 419 |
|
|
2019
Q3 | $2.26M | Buy |
44,261
+591
| +1% | +$28.1K | 0.04% | 446 |
|
|
2019
Q2 | $1.85M | Buy |
43,670
+112
| +0.3% | +$4.86K | 0.03% | 557 |
|
|
2019
Q1 | $2.15M | Buy |
43,558
+706
| +2% | +$31.9K | 0.04% | 458 |
|
|
2018
Q4 | $1.85M | Buy |
42,852
+766
| +2% | +$38.2K | 0.04% | 470 |
|
|
2018
Q3 | $2.39M | Sell |
42,086
-37
| -0.1% | -$1.95K | 0.04% | 419 |
|
|
2018
Q2 | $2.13M | Buy |
42,123
+659
| +2% | +$34.4K | 0.03% | 482 |
|
|
2018
Q1 | $2.07M | Buy |
41,464
+429
| +1% | +$20.2K | 0.03% | 519 |
|
|
2017
Q4 | $1.69M | Sell |
41,035
-74,420
| -64% | -$2.61M | 0.02% | 639 |
|
|
2017
Q3 | $3.43M | Sell |
115,455
-227
| -0.2% | -$6.93K | 0.02% | 765 |
|
|
2017
Q2 | $3.83M | Buy |
115,682
+1,363
| +1% | +$42.8K | 0.03% | 708 |
|
|
2017
Q1 | $3.39M | Sell |
114,319
-704
| -0.6% | -$19.2K | 0.02% | 773 |
|
|
2016
Q4 | $2.85M | Buy |
115,023
+63,934
| +125% | +$1.45M | 0.02% | 840 |
|
|
2016
Q3 | $1.15M | Hold |
51,089
| – | – | 0.01% | 1203 |
|
|
2016
Q2 | $1.22M | Buy |
51,089
+2,096
| +4% | +$50.3K | 0.01% | 1146 |
|
|
2016
Q1 | $1.16M | Buy |
48,993
+469
| +1% | +$11.5K | 0.01% | 1103 |
|
|
2015
Q4 | $1.35M | Hold |
48,524
| – | – | 0.01% | 1028 |
|
|
2015
Q3 | $1M | Hold |
48,524
| – | – | 0.01% | 1192 |
|
|
2015
Q2 | $1.25M | Sell |
48,524
-2,351
| -5% | -$59.5K | 0.01% | 1157 |
|
|
2015
Q1 | $1.28M | Hold |
50,875
| – | – | 0.01% | 1069 |
|
|
2014
Q4 | $1.21M | Hold |
50,875
| – | – | 0.01% | 1212 |
|
|
2014
Q3 | $1M | Hold |
50,875
| – | – | 0.01% | 1275 |
|
|
2014
Q2 | $1.22M | Buy |
50,875
+6,830
| +16% | +$165K | 0.01% | 1232 |
|
|
2014
Q1 | $1.17M | Hold |
44,045
| – | – | 0.01% | 1236 |
|
|
2013
Q4 | $889K | Hold |
44,045
| – | – | 0.01% | 1406 |
|
|
2013
Q3 | $769K | Hold |
44,045
| – | – | 0.01% | 1460 |
|
|
2013
Q2 | $743K | Buy |
+44,045
| New | +$680K | 0.01% | 1429 |
|
Other funds holding GMED
RI
CIP
Metropolitan Life Insurance Company (MetLife)'s GMED Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Globus Medical (GMED) in Q1 2022, closing a stake of 14,313 shares — an estimated $1.03M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in GMED in Q2 2013 and held it in 35 quarters. The position peaked at $3.83M in Q2 2017. 377 funds tracked by Wall St. Rank hold GMED as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Globus Medical position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 14,313 Globus Medical shares in Q1 2022, an estimated $1.03M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Globus Medical in Q2 2013 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Globus Medical position peaked at $3.83M in Q2 2017.
- 377 funds tracked by Wall St. Rank held Globus Medical as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.